Towards Healthcare

News

Your Daily Gateway to Essential News in Healthcare, Science, Technology and Business Worldwide

Functional Gut Clinic's new branch to digest all odds in the research space
22 January 2026

Functional Gut Clinic's new branch to digest all odds in the research space

Introduction Functional Gut Clinic (FGC), the expert face of modern gastrointestinal diagnostics, which also provides effective tests for conditions like leaky gut, reflux and IBS with the help of technology such as manometry, breath test, etc., is highly promoting its personalised clinical care. T...

Entheon and Nutravisor’s partnership to fuel the healthcare business
22 January 2026

Entheon and Nutravisor’s partnership to fuel the healthcare business

Introduction Entheon Biomedical Corp., a Canada-based biotech R&D entity, is focused on establishing psychedelic-related therapies with the help of DMT and commercialising its treatments to known physicians and clinics. The main business area of this company is psychedelic therapeutics, and the...

Novo celebrates Wegovy’s reach in this month of launch
22 January 2026

Novo celebrates Wegovy’s reach in this month of launch

Introduction A Danish-based multinational pharmaceutical company, Novo Nordisk, has been fighting serious chronic conditions since 1923 via innovative drugs to promote a long-term healthy lifestyle. Its main commercial areas are obesity and diabetes. Alongside the company’s new delivery syste...

Gosebruch promises to sail the ship with its oars of hardship
22 January 2026

Gosebruch promises to sail the ship with its oars of hardship

Introduction Henry Gosebruch, a G100 Next Gen graduate a valuable member of the board of directors at Acelyrin, known for its commendable work at AbbVie as a Former Executive Vice President and Chief Strategy Officer. The acquisitions, partnership management, and other business development speciali...

All eyes on promising future candidates that shed healing light on Alzheimer’s Treatment
21 January 2026

All eyes on promising future candidates that shed healing light on Alzheimer’s Treatment

Introduction Alzheimer’s condition is an active, speedy brain disorder that kills the brain’s thinking capacity and erases memories, making individuals feel hopeless, clueless and unaware of their life. This condition not only destroys patients’ lives but also their families and l...

Will Huron’s partnership idea help strengthen its AI-offered Healthcare transition?
21 January 2026

Will Huron’s partnership idea help strengthen its AI-offered Healthcare transition?

Introduction Hippocratic AI is a well-known company, developing safe and secure large language models (LLMs) for discovering new AI agents to enhance access to care, mitigate clinician stress and manage non-diagnostic tasks. The company’s models are well-revised and qualified by human smart m...

MEDvidi's new AI tool fill place of Mental Health Professionals
21 January 2026

MEDvidi's new AI tool fill place of Mental Health Professionals

Introduction MEDvidi is a leading online mental health treatment center that offers virtual therapy, medication and psychiatric care for different mental health conditions. Since 2019, the company has been serving the fastest and most affordable way through its online platform and has fixed the str...

Trump’s healthcare plan in the limelight
21 January 2026

Trump’s healthcare plan in the limelight

Introduction The 47th president of the United States, Mr Donald Trump, who’s also a businessman currently known for its popular tariffs and ‘One Big Beautiful Bill Act’ deal, is strongly making the highest impact in the United States’ economic, political, and market sectors....

Adolore’s Kv7-activating rdHSV-CA8 Therapy, now qualified for Erythromelalgia treatment
20 January 2026

Adolore’s Kv7-activating rdHSV-CA8 Therapy, now qualified for Erythromelalgia treatment

Introduction Adolore BioTherapeutics, a leading biotech face known for its consistent efforts for establishing gene-therapy related treatments for chronic pain with the help of creative and safe CA8 analgesic peptides and rdHSV vector for main delivery. The company is proving its role and responsib...

Hyundai Bioscience is getting closer to its Antiviral, XAFTY trial process succession
20 January 2026

Hyundai Bioscience is getting closer to its Antiviral, XAFTY trial process succession

Introduction Hyundai Bioscience, a well-known biotechnology company highly focused on establishing novel drug delivery systems (DDS) to advance and contribute to the existing drugs to spot precision in new therapeutic applications. Company been a member of the US Medical CBRN Defence Consortium (MC...